Tailoring therapy to the individual patient |
INTRODUCTION
The goals of therapy for type 2 diabetes are to prevent or delay complications and maintain quality of life. This requires control of glycaemia, management of cardiovascular risk factors, regular follow-up and ... |
Targets for glycaemic control in type 2 diabetes |
INTRODUCTION
Increasingly, day-to-day management of people with type 2 diabetes falls to general practice nurses (GPNs).1 It is therefore important that they are familiar with the latest guidelines, and understand how to apply ... |
Renal considerations in patients with type 2 diabetes |
INTRODUCTION
Renal impairment frequently co-exists with diabetes (type 1 and type 2).1 As many agents used to control blood glucose are metabolised by the kidneys, reduced renal function has important implications for the choice ... |
Cardiovascular considerations in patients with type 2 diabetes |
INTRODUCTION
The goals of treatment for type 2 diabetes are to prevent or delay complications and maintain quality of life.1 According to some international guidelines, this requires control not only of blood glucose levels, but ... |
Short-term complications of type 2 diabetes |
INTRODUCTION
Diabetes is associated with a number of complications of differing duration, complexity and severity that can occur during the management of blood glucose levels. This module is intended to develop understanding of the short ... |
Preventing type 2 diabetes |
Beverley Bostock RGN MSc MA QN
Advanced Nurse Practitioner, Mann Cottage Surgery, Gloucestershire
Council Member, Primary Care Cardiovascular Society
INTRODUCTION
Type 2 diabetes (T2D) is associated with ... |
Type 2 Diabetes: Diagnosis |
INTRODUCTION
Diabetes is one of the most common chronic diseases in the UK, and its prevalence is increasing.
There are approximately 3.5 million people with diagnosed diabetes, including ... |
Type 2 Diabetes: Management |
INTRODUCTION
The aim of management of type 2 diabetes is to control hyperglycaemia to minimise the risk of long term complications. This involves not only agreeing and setting individualised targets for HbA1c, and ... |
|
|